XML 38 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Option Plan and Stock Based Compensation (Tables)
 12 Months Ended
Feb. 29, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Options

The following occurred with respect to the Company’s stock options for each of the three years ended February 29, 2020:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

Number

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

of Shares

 

 

Exercise

 

 

Contractual

 

 

Value(a)

 

 

 

(exact quantity)

 

 

Price

 

 

Life (in years)

 

 

(in thousands)

 

Outstanding at March 1, 2017

 

 

172,496

 

 

$

15.95

 

 

 

4.2

 

 

$

223

 

Granted

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Terminated

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Exercised

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Outstanding at February 28, 2018

 

 

172,496

 

 

$

15.95

 

 

 

3.2

 

 

$

612

 

Granted

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Terminated

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Exercised

 

 

(110,906

)

 

 

15.99

 

 

 

 

 

 

 

 

 

Outstanding at February 28, 2019

 

 

61,590

 

 

$

15.88

 

 

 

1.8

 

 

$

327

 

Granted

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Terminated

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Exercised

 

 

(61,590

)

 

$

15.88

 

 

 

 

 

 

 

 

 

Outstanding at February 29, 2020

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Exercisable at February 29, 2020

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

(a)

Intrinsic value is measured as the excess fair market value of the Company’s common stock as reported on the NYSE over the applicable exercise price.

Summary of Stock Options Exercised and Tax Benefits Realized from Stock Based Compensation

A summary of the stock options exercised and tax benefits realized from stock based compensation is presented below for the three fiscal years ended (in thousands):

 

 

 

Fiscal years ended

 

 

 

2020

 

 

2019

 

 

2018

 

Total cash received

 

$

—

 

 

$

69

 

 

$

—

 

Total grant-date fair value

 

 

201

 

 

 

345

 

 

 

—

 

Intrinsic value

 

 

267

 

 

 

534

 

 

 

—

 
Summary of Restricted Stock Awards

The following occurred with respect to the Company’s restricted stock awards for each of the three fiscal years ended February 29, 2020:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

Number of

 

 

Grant Date

 

 

Shares

 

 

Fair Value

 

Outstanding at March 1, 2017

 

166,546

 

 

$

16.35

 

Granted

 

74,900

 

 

 

16.30

 

Terminated

 

—

 

 

 

—

 

Vested

 

(88,771

)

 

 

15.90

 

Outstanding at February 28, 2018

 

152,675

 

 

$

16.59

 

Granted

 

83,789

 

 

 

20.54

 

Terminated

 

—

 

 

 

—

 

Vested

 

(81,359

)

 

 

16.01

 

Outstanding at February 28, 2019

 

155,105

 

 

$

19.03

 

Granted

 

66,669

 

 

 

20.41

 

Terminated

 

(3,920

)

 

 

17.02

 

Vested

 

(73,928

)

 

 

18.90

 

Outstanding at February 29, 2020

 

143,926

 

 

$

19.79